Recent Quotes
My Watchlist
Indicators
REW 40 Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Avita Medical, Inc. - Common Stock (NQ:RCEL)

3.910 +0.160 (+4.27%)
Streaming Delayed Price Updated: 4:00 PM EST, Nov 26, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Avita Medical, Inc. - Common Stock

< Previous 1 2 3 4 5 Next >
News headline image
AVITA Medical to Present at the Piper Sandler 37ᵗʰ Annual Healthcare Conference
From AVITA Medical
Via GlobeNewswire
News headline image
Bragar Eagel & Squire, P.C. Encourages Agilon, Soleno, Avita, and Coty Investors to Contact the Firm Regarding Ongoing Investigations
From Bragar Eagel & Squire
Via GlobeNewswire
News headline image
Bragar Eagel & Squire, P.C. Is Investigating Agilon, Soleno, Avita, and Coty and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
News headline image
AVITA Medical to Host Investor Webinar Briefing
From AVITA Medical
Via GlobeNewswire
News headline image
AVITA® Medical Reports Third Quarter 2025 Financial Results
From AVITA Medical
Via GlobeNewswire
News headline image
Data Presented at the 2025 Southern Region Burn Conference Reinforce RECELL® System as a Standard of Care in Acute Wound Treatment
Global evidence and real-world data demonstrate the clinical, operational, and economic impact of AVITA Medical’s RECELL System across wound types and patient populations 
From AVITA Medical
Via GlobeNewswire
News headline image
AVITA Medical to Announce Third Quarter 2025 Financial Results
From AVITA Medical
Via GlobeNewswire
News headline image
Rosen Law Firm Encourages AVITA Medical, Inc. Investors to Inquire About Securities Class Action Investigation – RCEL
From The Rosen Law Firm, P.A.
Via Business Wire
News headline image
AVITA Medical Welcomes Support for RECELL® in Burns in Australia
From AVITA Medical
Via GlobeNewswire
News headline image
AVITA Medical Announces CEO Transition
From AVITA Medical
Via GlobeNewswire
News headline image
AVITA MEDICAL INVESTIGATION: Bragar Eagel & Squire, P.C. Reminds AVITA Medical Investors to Contact the Firm Regarding the Ongoing Investigation on Behalf of Stockholders
From Bragar Eagel & Squire
Via GlobeNewswire
News headline image
AVITA REMINDER: Bragar Eagel & Squire, P.C. Reminds AVITA Medical Investors to Contact the Firm Regarding the Ongoing Investigation on Behalf of Stockholders
From Bragar Eagel & Squire
Via GlobeNewswire
News headline image
AVITA (RCEL) INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. Continues Investigation into AVITA Medical, Inc. and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
News headline image
CMS New Technology Add-On Payment Expands Access to RECELL® for Patients with Non-Burn Acute Wounds
From AVITA Medical
Via GlobeNewswire
News headline image
AVITA INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. is Investigating AVITA Medical, Inc. on Behalf of Avita Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of AVITA Medical, Inc. - RCEL
From Pomerantz LLP
Via GlobeNewswire
News headline image
AVITA ALERT: Bragar Eagel & Squire, P.C. is Investigating AVITA Medical, Inc. on Behalf of Avita Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
News headline image
AVITA Medical Receives CE Mark for RECELL® GO, Enabling Commercialization Across Europe
From AVITA Medical
Via GlobeNewswire
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of AVITA Medical, Inc. - RCEL
From Pomerantz LLP
Via GlobeNewswire
News headline image
RCEL Investors Have Opportunity to Join AVITA Medical, Inc. Fraud Investigation with the Schall Law Firm
From The Schall Law Firm
Via Business Wire
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of AVITA Medical, Inc. - RCEL
From Pomerantz LLP
Via GlobeNewswire
News headline image
RCEL Alert: Kirby McInerney LLP Encourages AVITA Medical, Inc. Investors to Inquire about Investigation
From Kirby McInerney LLP
Via Business Wire
News headline image
AVITA ALERT: Bragar Eagel & Squire, P.C. is Investigating AVITA Medical, Inc. on Behalf of Avita Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
News headline image
Bragar Eagel & Squire, P.C. Is Investigating Avita, Coty, and Sensus and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
News headline image
Real-World Data Shows Significant Reduction in Hospital Stay Using AVITA Medical’s RECELL® System
From AVITA Medical
Via GlobeNewswire
News headline image
AVITA ALERT: Bragar Eagel & Squire, P.C. is Investigating AVITA Medical, Inc. on Behalf of Avita Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
News headline image
Kirby McInerney LLP Announces Investigation Against AVITA Medical, Inc. on Behalf of Investors
From Kirby McInerney LLP
Via GlobeNewswire
News headline image
AVITA Medical Announces September Investor Conference Participation
From AVITA Medical
Via GlobeNewswire
News headline image
Securities Fraud Investigation Into AVITA Medical, Inc. (RCEL) Announced – Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm
From Glancy Prongay & Murray LLP
Via Business Wire
News headline image
AVITA Medical, Inc. (RCEL) Investors Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation
From Law Offices of Howard G. Smith
Via Business Wire
< Previous 1 2 3 4 5 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.